Additionally, VOC has been recently associated with complement activation (50), and C5a infusion was shown to induce VOC in murine SCD models, an effect that could be blocked by targeting either C5a or C5aR (51). The gene discussed is C5AR1; the disease is Schnyder corneal dystrophy.